VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS)
Condition(s):High-risk Percutaneous Coronary Intervention; Heart Disease, CoronaryLast Updated:March 19, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):High-risk Percutaneous Coronary Intervention; Heart Disease, CoronaryLast Updated:March 19, 2024Not yet recruiting
Condition(s):Mitral Valve Regurgitation; Mitral Valve Prolapse; Mitral Valve InsufficiencyLast Updated:January 22, 2024Completed
Condition(s):Ventricular Tachycardia; Arrythmia; Heart Diseases; Cardiovascular DiseasesLast Updated:August 10, 2022Completed
Condition(s):Adenosine Deaminase Severe Combined Immune DeficiencyLast Updated:January 26, 2023Recruiting
Condition(s):ADA-SCIDLast Updated:August 3, 2022Completed
Condition(s):Tricuspid RegurgitationLast Updated:April 3, 2023Active, not recruiting
Condition(s):High-risk Percutaneous Coronary InterventionLast Updated:October 27, 2023Recruiting
Condition(s):Mitral Regurgitation; Mitral DiseaseLast Updated:June 7, 2023Active, not recruiting
Condition(s):High-risk Percutaneous Coronary InterventionLast Updated:March 28, 2024Active, not recruiting
Condition(s):Severe Combined Immunodeficiency Due to ADA DeficiencyLast Updated:August 3, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.